Search Results

There are 103569 results for: content related to: Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy

  1. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2228

  2. Targeted therapy for advanced renal cell carcinoma

    Intervention Review

    The Cochrane Library

    Chris Coppin, Lyly Le, Timothy J Wilt and Christian Kollmannsberger

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006017.pub2

  3. You have free access to this content
    Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials

    BJU International

    Volume 108, Issue 10, November 2011, Pages: 1556–1563, Chris Coppin, Christian Kollmannsberger, Lyly Le, Franz Porzsolt and Timothy J. Wilt

    Version of Record online : 27 SEP 2011, DOI: 10.1111/j.1464-410X.2011.10629.x

  4. You have free access to this content
    Publications

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 244–321,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2229

  5. You have free access to this content
    Oral Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 100–180,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2227

  6. SIOP 2015 Scientific Programme + Index

    Pediatric Blood & Cancer

    Volume 62, Issue S4, November 2015, Pages: S143–S418,

    Version of Record online : 9 SEP 2015, DOI: 10.1002/pbc.25715

  7. You have free access to this content
    RESEARCH PODIUM ABSTRACTS

    Value in Health

    Volume 12, Issue 7, October 2009, Pages: A221–A237,

    Version of Record online : 15 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00592_1.x

    Corrected by:

    Erratum

    Vol. 13, Issue 2, 335, Version of Record online: 17 DEC 2009

  8. You have free access to this content
    Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

    BJU International

    Volume 108, Issue 8b, October 2011, Pages: E250–E257, Camillo Porta, Giuseppe Procopio, Giacomo Cartenì, Roberto Sabbatini, Alessandra Bearz, Isabella Chiappino, Enzo Maria Ruggeri, Giovanni Lo Re, Riccardo Ricotta, Fable Zustovich, Lorenza Landi, Anna Calcagno, Ilaria Imarisio, Elena Verzoni, Mimma Rizzo, Chiara Paglino, Valentina Guadalupi and Emilio Bajetta

    Version of Record online : 23 MAY 2011, DOI: 10.1111/j.1464-410X.2011.10186.x

  9. You have free access to this content
    Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma

    Value in Health

    Volume 13, Issue 1, January/February 2010, Pages: 61–68, Martin Hoyle, Colin Green, Jo Thompson-Coon, Zulian Liu, Karen Welch, Tiffany Moxham and Ken Stein

    Version of Record online : 25 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00617.x

  10. You have free access to this content
    RESEARCH POSTER ABSTRACTS

    Value in Health

    Volume 12, Issue 7, October 2009, Pages: A237–A460,

    Version of Record online : 15 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00592_2.x

    Corrected by:

    Erratum

    Vol. 13, Issue 1, 158, Version of Record online: 17 DEC 2009

  11. You have full text access to this OnlineOpen article
    New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma

    Cancer

    Volume 118, Issue 6, 15 March 2012, Pages: 1486–1497, Mark Agulnik

    Version of Record online : 11 AUG 2011, DOI: 10.1002/cncr.26361

  12. You have free access to this content
    ORAL PRESENTATIONS

    Hematological Oncology

    Volume 31, Issue S1, June 2013, Pages: 96–150,

    Version of Record online : 17 JUN 2013, DOI: 10.1002/hon.2057

  13. You have free access to this content
    Current status of pharmacotherapy against metastatic renal cell carcinoma in Japan

    International Journal of Urology

    Volume 19, Issue 4, April 2012, Pages: 284–295, Yoshihiro Wada, Wataru Takahashi, Yoshiaki Kawano and Masatoshi Eto

    Version of Record online : 27 MAR 2012, DOI: 10.1111/j.1442-2042.2012.02962.x

  14. You have free access to this content
    A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study

    Cancer

    Volume 121, Issue 19, October 1, 2015, Pages: 3465–3471, Timothy S. Fenske, Namrata M. Shah, Kyung Mann Kim, Sandeep Saha, Chong Zhang, Arielle E. Baim, John P. Farnen, Adedayo A. Onitilo, Jules H. Blank, Harish Ahuja, Tim Wassenaar, Rubina Qamar, Patrick Mansky, Anne M. Traynor, Ryan J. Mattison and Brad S. Kahl

    Version of Record online : 16 JUN 2015, DOI: 10.1002/cncr.29502

  15. You have free access to this content
    Therapeutic concepts in mantle cell lymphoma

    European Journal of Haematology

    Volume 85, Issue 5, November 2010, Pages: 371–386, Jose Rodriguez, Antonio Gutierrez, Antonia Obrador-Hevia, Silvia Fernandez de Mattos and Fernando Cabanillas

    Version of Record online : 21 OCT 2010, DOI: 10.1111/j.1600-0609.2010.01515.x

  16. You have free access to this content
    Optimal management of metastatic renal cell carcinoma: an algorithm for treatment

    BJU International

    Volume 104, Issue 1, July 2009, Pages: 10–18, Joaquim Bellmunt, Per Flodgren, Jan Roigas and Stéphane Oudard

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1464-410X.2009.08563.x

  17. You have free access to this content
    Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy

    Cancer

    Volume 118, Issue 24, 15 December 2012, Pages: 6055–6062, Daniel C. Cho, Thomas E. Hutson, Wolfram Samlowski, Peter Sportelli, Brad Somer, Paul Richards, Jeffrey A. Sosman, Igor Puzanov, M. Dror Michaelson, Keith T. Flaherty, Robert A. Figlin and Nicholas J. Vogelzang

    Version of Record online : 6 JUN 2012, DOI: 10.1002/cncr.27668

  18. Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignancies

    Clinical Pharmacology & Therapeutics

    Volume 97, Issue 5, May 2015, Pages: 455–468, Y Wang, LL Zhang, RE Champlin and ML Wang

    Version of Record online : 3 APR 2015, DOI: 10.1002/cpt.85

  19. You have free access to this content
    A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcoma

    International Journal of Cancer

    Volume 133, Issue 4, 15 August 2013, Pages: 997–1005, K.A. Thornton, A.R. Chen, M.M. Trucco, P. Shah, B.A. Wilky, N. Gul, M.A. Carrera-Haro, M. Fogle Ferreira, U. Shafique, J.D. Powell, C.F. Meyer and D.M. Loeb

    Version of Record online : 4 MAR 2013, DOI: 10.1002/ijc.28083

  20. You have free access to this content
    Current management and future perspectives of metastatic renal cell carcinoma

    International Journal of Urology

    Volume 21, Issue 9, September 2014, Pages: 847–855, Richard Lee-Ying, Renee Lester and Daniel YC Heng

    Version of Record online : 27 MAY 2014, DOI: 10.1111/iju.12502